3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Triple Negative Breast Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Osteosarcoma
1
Neoplasms
1
Myelodysplastic Syndromes
1
Mesothelioma, Malignant
1
Mesothelioma
1
Lymphoma, Non-Hodgkin
1
Leukemia, Prolymphocytic, B-Cell
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Myeloid, Acute
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Leukemia, Biphenotypic, Acute
1
Kidney Neoplasms
1
Glioma
1
Colorectal Neoplasms
1
Carcinoma, Renal Cell
1
Carcinoma, Non-Small-Cell Lung
1
Burkitt Lymphoma
1
Interventions
Biopsy
17
Specimen Handling
16
Magnetic Resonance Spectroscopy
15
Cyclophosphamide
14
Rituximab
12
obinutuzumab
8
Lenalidomide
8
fludarabine
7
Prednisone
7
pembrolizumab
6
Nuclear Medicine Department, Hospital
6
Doxorubicin
5
glofitamab
4
fludarabine phosphate
4
X-Rays
4
Vincristine
4
Tacrolimus
4
Mycophenolic Acid
4
Etoposide
4
Busulfan
4
venetoclax
3
trametinib
3
sapanisertib
3
ibrutinib
3
copanlisib
3
acalabrutinib
3
Whole-Body Irradiation
3
Nivolumab
3
GSK2636771
3
Crizotinib
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoma
×
Blood Component Removal
×
30 days
×
Clear all
No trials found.